Sequential administration of sclerostin antibody and parathyroid hormone differentially modulates fracture healing in a murine tibial osteotomy model
Atsushi Mihara, Kiminori Yukata, Norihiro Nishida, Tetsuya Seto, Ryuta Iwanaga, Kenzo Fujii, Kazuya Uehara, Yuji Saeki · 2026
Read Sequential administration of sclerostin antibody and parathyroid hormone differentially modulates fracture healing in a murine tibial osteotomy model by Atsushi Mihara, Kiminori Yukata, Norihiro Nishida, Tetsuya Seto, Ryuta Iwanaga, Kenzo Fujii, Kazuya Uehara, Yuji Saeki (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354181.txt.
Description
Atsushi Mihara and seven colleagues test whether the order of two bone-building drugs changes how fractures heal, in this 2026 PLOS ONE mouse study. Both drugs help bones grow, but through different machinery: one mimics a parathyroid hormone signal, the other blocks a protein that brakes bone formation. Mice with a surgically cut shin bone received one drug alone, or one drug for a week and then the other.
Starting with the blocking antibody and switching to the hormone gave denser healing tissue and stronger bones than the reverse order, at equal total exposure. Cartilage lingered longer in the hormone-first groups, a sign of slower progress. Sequence, not just drug choice, may matter in fracture care.
Catalog record
| CREATOR | Atsushi Mihara, Kiminori Yukata, Norihiro Nishida, Tetsuya Seto, Ryuta Iwanaga, Kenzo Fujii, Kazuya Uehara, Yuji Saeki |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28679 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |